Mesenchymal stem cells (MSCs), components of this microenvironment, have been increasingly recognized for their role in enhancing cancer progression through metabolic reprogramming induced by colony-stimulating factor 2 (CSF2) produced through Notch1 ubiquitination. This evidence concerns the gene CSF2 and cancer.